These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15076223)

  • 1. Chronic treatment with rilmenidine in spontaneously hypertensive rats: differences between two schedules of administration.
    Monassier L; Greney H; Thomas L; Bousquet P
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):394-401. PubMed ID: 15076223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
    Sannajust F; Head GA
    Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central actions of agmatine in conscious spontaneously hypertensive rats.
    Briaud S; Zhang BL; Sannajust F
    Clin Exp Hypertens; 2005 Nov; 27(8):619-27. PubMed ID: 16303638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats.
    Estato V; Araújo CV; Bousquet P; Tibiriçá E
    Braz J Med Biol Res; 2004 Oct; 37(10):1541-9. PubMed ID: 15448876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of anaesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats.
    Sannajust F; Cerutti C; Koenig-Bérard E; Sassard J
    Br J Pharmacol; 1992 Mar; 105(3):542-8. PubMed ID: 1352719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol selectively counteracts hypotension evoked by central I(1)-imidazoline but not alpha2-adrenergic receptor activation in spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):382-9. PubMed ID: 9733351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of rilmenidine on neurogenic hypertension in BPH/2J genetically hypertensive mice.
    Jackson KL; Palma-Rigo K; Nguyen-Huu TP; Davern PJ; Head GA
    J Hypertens; 2014 Mar; 32(3):575-86. PubMed ID: 24275840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotid arterial changes produced by a centrally mediated antihypertensive agent in hypertensive rats.
    Levy BI; Dabire H; Poitevin P; Safar ME
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):666-73. PubMed ID: 8569231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats.
    Koenig-Berard E; Tierney C; Beau B; Delbarre G; Lhoste F; Labrid C
    Am J Cardiol; 1988 Feb; 61(7):22D-31D. PubMed ID: 2894153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rilmenidine on arterial pressure and urinary output in the spontaneously hypertensive rat.
    Cechetto DF; Kline RL
    Eur J Pharmacol; 1997 Apr; 325(1):47-55. PubMed ID: 9151938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of continuous infusions (10 days) and cessation of infusions of clonidine and rilmenidine (S 3341) on cardiovascular and behavioral parameters of spontaneously hypertensive rats.
    Jarrott B; Lewis SJ; Doyle AE; Louis WJ
    Am J Cardiol; 1988 Feb; 61(7):39D-44D. PubMed ID: 2894156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central I1-imidazoline receptors as targets of centrally acting antihypertensive drugs. Clinical pharmacology of moxonidine and rilmenidine.
    Van Zwieten PA; Peters SL
    Ann N Y Acad Sci; 1999 Jun; 881():420-9. PubMed ID: 10415946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypotensive action of rilmenidine is dependent on functional N-methyl-D-aspartate receptor in the rostral ventrolateral medulla of conscious spontaneously hypertensive rats.
    Zhang J; Abdel-Rahman AA
    J Pharmacol Exp Ther; 2002 Oct; 303(1):204-10. PubMed ID: 12235252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional hemodynamic effects of rilmenidine and clonidine in the conscious spontaneously hypertensive rat.
    Smits JF; Struyker-Boudier HA
    Fundam Clin Pharmacol; 1991; 5(8):651-61. PubMed ID: 1783359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-effect relationship of rilmenidine after chronic administration.
    Luccioni R; Lambert M; Ambrosi P; Scemama M
    Eur J Clin Pharmacol; 1993; 45(2):157-60. PubMed ID: 8223838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats.
    Janssen BJ; Oosting J; Tyssen CM; Struyker-Boudier HA
    Chronobiol Int; 1993 Dec; 10(6):420-34. PubMed ID: 8111867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathoinhibitory effects of rilmenidine may be mediated by sites located below the brainstem.
    Sannajust F; Barrès C; Koenig-Bérard E; Sassard J
    Br J Pharmacol; 1992 Mar; 105(3):535-41. PubMed ID: 1352718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with quinpirole inhibits the central antihypertensive effects of rilmenidine and alpha-methyldopa in conscious rats.
    Van den Buuse M
    Eur J Pharmacol; 1997 Mar; 322(2-3):191-9. PubMed ID: 9098687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the pharmacology of rilmenidine.
    Montastruc JL; Macquin-Mavier I; Tran MA; Damase-Michel C; Koenig-Berard E; Valet P
    Am J Med; 1989 Sep; 87(3C):14S-17S. PubMed ID: 2571291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.